Subgroup analyses of outcomes in very highly sensitised patients (cRF 98%–100%) and in deceased donor kidney transplants are outlined in Supplementary File 1 [3], [4] ; patient and allograft outcomes followed similar trends to the wider cohort, albeit did not reach statistical significance for all outcomes.
← all excerpts
Kidney Transplant Outcomes With Non-Depleting Antibody Induction Therapy in Human Leucocyte Antigen Sensitised Recipients.
1
—
—